The clinical landscape of chronic graft‐versus‐host disease management in 2021

NG Holtzman, SZ Pavletic - British Journal of Haematology, 2022 - Wiley Online Library
Chronic graft‐versus‐host disease (cGVHD) is an important systemic complication of
allogeneic haematopoietic stem cell transplantation with heterogeneous, multi‐organ …

Comparable meibomian gland changes in patients with and without ocular graft-versus-host disease after hematopoietic stem cell transplantation

W Zhao, J Yang, Y Liao, HY Lao, Q Huang, L Jin… - The Ocular Surface, 2022 - Elsevier
Purpose To compare the presentation and severity of meibomian gland dysfunction (MGD)
in patients with and without chronic ocular graft-versus-host disease (coGVHD) after …

Vision-specific and cancer-specific quality of life in ocular graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Y Liao, W Zhao, J Yang, S Wu, L Jin, F Huang… - Graefe's Archive for …, 2023 - Springer
Purpose To compare the vision-specific and cancer-specific quality of life (QOL) between
patients with and without ocular graft-versus-host disease (oGVHD) after allogeneic …

Lifitegrast ophthalmic solution for treatment of ocular chronic graft-versus-host disease

S Chhabra, JH Jerkins, JE Conto, K Zellner… - Leukemia & …, 2020 - Taylor & Francis
Ocular chronic graft-versus-host disease (oGVHD) is a relatively common complication that
occurs following allogeneic hematopoietic cell transplantation. Keratoconjunctivitis sicca …

[HTML][HTML] Ocular surface disease index questionnaire as a sensitive test for primary screening of chronic ocular graft-versus-host disease

J Yang, W Zhao, Y Liao, S Wu, J Li, L Jin… - Annals of …, 2022 - ncbi.nlm.nih.gov
Background After allogeneic hematopoietic stem cell transplantation (allo-HSCT), patients
are followed up by transplant clinicians. Finding an effective primary screening method that …

[HTML][HTML] A randomized trial of topical fibrinogen-depleted human platelet lysate treatment of dry eye secondary to chronic graft-versus-host disease

A Sugar, M Hussain, W Chamberlain, R Dana… - Ophthalmology …, 2022 - Elsevier
Purpose The purpose of the study was to evaluate, as a pilot trial, safety and tolerability of
CAM-101 10% and 30% topical ophthalmic fibrinogen-depleted human platelet lysate (FD …

[HTML][HTML] Observation of chronic graft-versus-host disease mouse model cornea with in vivo confocal microscopy

S Shimizu, S Sato, H Taniguchi, E Shimizu, J He… - Diagnostics, 2021 - mdpi.com
Graft-versus-host disease (GVHD) is a major complication after hematopoietic stem cell
transplantation (HSCT), and ocular GVHD can cause severe dry eye disease that can lead …

The association between meibomian gland atrophy and corneal subbasal nerve loss in patients with chronic ocular graft-versus-host disease

O Dikmetas, S Kocabeyoglu, MC Mocan - Current Eye Research, 2021 - Taylor & Francis
Purpose: To investigate the association between meibomian gland (MG) loss and corneal
subbasal nerve plexus density in patients with chronic graft-versus-host disease (GVHD) …

[HTML][HTML] Assessing long-term effects after stem cell transplantation: design of the MOSA study

B Wauben, NC van Yperen, MWM van der Poel… - Journal of Clinical …, 2022 - Elsevier
Abstract Objectives The MOSA study (Maastricht Observational study of late effects after
Stem cell trAnsplantation) aims to study the prevalence of adverse health effects in …

[HTML][HTML] Local renin-angiotensin system activation and myofibroblast formation in graft versus host disease–associated conjunctival fibrosis

K Shamloo, J Weng, C Ross, J Lee… - … & visual science, 2021 - iovs.arvojournals.org
Purpose: The present study was designed to investigate the role of myofibroblast
transdifferentiation and the conjunctival renin–angiotensin system (RAS) in the …